Kuiper J - Search Results

1

The role of mast cells in atherosclerosis.

Wezel A, Quax PH, Kuiper J, Bot I. Wezel A, et al. Among authors: kuiper j. Hamostaseologie. 2015;35(2):113-20. doi: 10.5482/HAMO-14-08-0034. Epub 2014 Nov 7. Hamostaseologie. 2015. PMID: 25377048 Review.

2

Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo.

Quax PH, van den Hoogen CM, Verheijen JH, Padro T, Zeheb R, Gelehrter TD, van Berkel TJ, Kuiper J, Emeis JJ. Quax PH, et al. Among authors: kuiper j. J Biol Chem. 1990 Sep 15;265(26):15560-3. J Biol Chem. 1990. PMID: 2118527 Free article.

3

Interleukins in atherosclerosis: molecular pathways and therapeutic potential.

von der Thüsen JH, Kuiper J, van Berkel TJ, Biessen EA. von der Thüsen JH, et al. Among authors: kuiper j. Pharmacol Rev. 2003 Mar;55(1):133-66. doi: 10.1124/pr.55.1.5. Pharmacol Rev. 2003. PMID: 12615956 Review.

4

Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/-mice.

Bot I, von der Thüsen JH, Donners MM, Lucas A, Fekkes ML, de Jager SC, Kuiper J, Daemen MJ, van Berkel TJ, Heeneman S, Biessen EA. Bot I, et al. Among authors: kuiper j. Circ Res. 2003 Sep 5;93(5):464-71. doi: 10.1161/01.RES.0000090993.01633.D4. Epub 2003 Aug 14. Circ Res. 2003. PMID: 12919945

5

Identification of an internalising peptide in differentiated Calu-3 cells by phage display technology; application to gene delivery to the airways.

Florea BI, Molenaar TJ, Bot I, Michon IN, Kuiper J, Van Berkel TJ, Junginger HE, Biessen EA, Borchard G. Florea BI, et al. Among authors: kuiper j. J Drug Target. 2003 Aug;11(7):383-90. doi: 10.1080/10611860310001642389. J Drug Target. 2003. PMID: 15203927

6

Scavenger receptors: friend or foe in atherosclerosis?

van Berkel TJ, Out R, Hoekstra M, Kuiper J, Biessen E, van Eck M. van Berkel TJ, et al. Among authors: kuiper j. Curr Opin Lipidol. 2005 Oct;16(5):525-35. doi: 10.1097/01.mol.0000183943.20277.26. Curr Opin Lipidol. 2005. PMID: 16148537 Review.

7

Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.

van Puijvelde GH, Hauer AD, de Vos P, van den Heuvel R, van Herwijnen MJ, van der Zee R, van Eden W, van Berkel TJ, Kuiper J. van Puijvelde GH, et al. Among authors: kuiper j. Circulation. 2006 Oct 31;114(18):1968-76. doi: 10.1161/CIRCULATIONAHA.106.615609. Epub 2006 Oct 23. Circulation. 2006. PMID: 17060383

8

Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis.

Hauer AD, van Puijvelde GH, Peterse N, de Vos P, van Weel V, van Wanrooij EJ, Biessen EA, Quax PH, Niethammer AG, Reisfeld RA, van Berkel TJ, Kuiper J. Hauer AD, et al. Among authors: kuiper j. Arterioscler Thromb Vasc Biol. 2007 Sep;27(9):2050-7. doi: 10.1161/ATVBAHA.107.143743. Epub 2007 Jun 28. Arterioscler Thromb Vasc Biol. 2007. PMID: 17600223

9

Immunomodulation of the inflammatory response in atherosclerosis.

Kuiper J, van Puijvelde GH, van Wanrooij EJ, van Es T, Habets K, Hauer AD, van den Berkel TJ. Kuiper J, et al. Curr Opin Lipidol. 2007 Oct;18(5):521-6. doi: 10.1097/MOL.0b013e3282efd0d4. Curr Opin Lipidol. 2007. PMID: 17885422 Review.

10

Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis.

van Puijvelde GH, van Es T, van Wanrooij EJ, Habets KL, de Vos P, van der Zee R, van Eden W, van Berkel TJ, Kuiper J. van Puijvelde GH, et al. Among authors: kuiper j. Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2677-83. doi: 10.1161/ATVBAHA.107.151274. Epub 2007 Sep 27. Arterioscler Thromb Vasc Biol. 2007. PMID: 17901374

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

823 results

Search Page